• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西非国家耐多药结核分枝杆菌的出现,以科特迪瓦为重点。

Emergence in Western African countries of MDR-TB, focus on Côte d'Ivoire.

机构信息

Département de Bactériologie-Virologie, Institut Pasteur de Côte d'Ivoire, 01 BP 490 Abidjan 01, Cote D'Ivoire ; Thérapeutiques Cliniques et Expérimentales des Infections, Département des Maladies Infectieuses UFR de Médecine, 1, rue Gaston Veil, 44035 Nantes Cedex, France.

出版信息

Biomed Res Int. 2013;2013:426709. doi: 10.1155/2013/426709. Epub 2013 Sep 4.

DOI:10.1155/2013/426709
PMID:24093098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3777174/
Abstract

Tuberculosis (TB) is responsible for a high mortality rate (2.5%) worldwide, mainly in developing countries with a high prevalence of human immunodeficiency virus (HIV). The emergence of multiresistant strains of TB poses an extreme risk for TB outbreaks and highlights the need for global TB control strategies. Among Western African countries, Côte d'Ivoire (CI) represents a specific example of a country with great potential to prevent TB. Specifically, CI has a promising healthcare system for monitoring diseases, including vaccination programs. However, military and political conflict in CI favors the spread of infectious diseases, TB being among the most devastating. Compilation of the studies identifying common causes of TB would be extremely beneficial for the development of treatment and prevention strategies. Therefore, the purpose of this comprehensive review is to evaluate the epidemiology of TB in CI, describe the factors involved in pathogenesis, and suggest simple and applicable prevention strategies.

摘要

结核病(TB)在全球范围内导致高死亡率(2.5%),主要发生在艾滋病毒(HIV)高发的发展中国家。耐多药结核菌株的出现对结核病爆发构成了极端风险,凸显了制定全球结核病控制策略的必要性。在西非国家中,科特迪瓦(CI)是一个具有巨大潜力来预防结核病的国家的具体例子。具体而言,CI 拥有用于监测疾病(包括疫苗接种计划)的有前途的医疗保健系统。然而,CI 的军事和政治冲突有利于传染病的传播,结核病是其中最具破坏性的疾病之一。综合研究结核病的常见病因将非常有助于制定治疗和预防策略。因此,本综述的目的是评估 CI 结核病的流行病学,描述发病机制涉及的因素,并提出简单适用的预防策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8d5/3777174/c855f4d884cd/BMRI2013-426709.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8d5/3777174/57348829a7aa/BMRI2013-426709.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8d5/3777174/b86dde135ee7/BMRI2013-426709.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8d5/3777174/c855f4d884cd/BMRI2013-426709.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8d5/3777174/57348829a7aa/BMRI2013-426709.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8d5/3777174/b86dde135ee7/BMRI2013-426709.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8d5/3777174/c855f4d884cd/BMRI2013-426709.003.jpg

相似文献

1
Emergence in Western African countries of MDR-TB, focus on Côte d'Ivoire.西非国家耐多药结核分枝杆菌的出现,以科特迪瓦为重点。
Biomed Res Int. 2013;2013:426709. doi: 10.1155/2013/426709. Epub 2013 Sep 4.
2
The Côte d'Ivoire national HIV counseling and testing program for tuberculosis patients: implementation and analysis of epidemiologic data.科特迪瓦针对结核病患者的国家艾滋病毒咨询与检测项目:流行病学数据的实施与分析
AIDS. 1998 Mar 26;12(5):505-12. doi: 10.1097/00002030-199805000-00012.
3
Estimates of serious fungal infection burden in Côte d'Ivoire and country health profile.科特迪瓦严重真菌感染负担估计和国家卫生概况。
J Mycol Med. 2021 Mar;31(1):101086. doi: 10.1016/j.mycmed.2020.101086. Epub 2020 Nov 21.
4
The relationship between depression and sexual health service utilization among men who have sex with men (MSM) in Côte d'Ivoire, West Africa.西非科特迪瓦男男性行为者(MSM)中抑郁症与性健康服务利用之间的关系。
BMC Int Health Hum Rights. 2019 Mar 5;19(1):11. doi: 10.1186/s12914-019-0186-6.
5
Male Circumcision and the Epidemic Emergence of HIV-2 in West Africa.男性包皮环切术与西非HIV-2的流行出现
PLoS One. 2016 Dec 7;11(12):e0166805. doi: 10.1371/journal.pone.0166805. eCollection 2016.
6
Wide Variations in Compliance with Tuberculosis Screening Guidelines and Tuberculosis Incidence between Antiretroviral Therapy Facilities - Côte d'Ivoire.抗逆转录病毒治疗机构间结核病筛查指南依从性和结核病发病率的广泛差异——科特迪瓦
PLoS One. 2016 Jun 8;11(6):e0157059. doi: 10.1371/journal.pone.0157059. eCollection 2016.
7
Characterizing social cohesion and gender identity as risk determinants of HIV among cisgender men who have sex with men and transgender women in Côte d'Ivoire.描述社会凝聚力和性别认同作为科特迪瓦与男性发生性行为的顺性别男性和跨性别女性中 HIV 的风险决定因素。
Ann Epidemiol. 2020 Feb;42:25-32. doi: 10.1016/j.annepidem.2019.11.003. Epub 2019 Dec 16.
8
Decrease of human immunodeficiency virus prevalence in antenatal clinics in Abidjan, Côte d'Ivoire, 1995-2002.1995 - 2002年科特迪瓦阿比让产前诊所人类免疫缺陷病毒流行率的下降情况
Int J STD AIDS. 2006 Jan;17(1):57-60. doi: 10.1258/095646206775220559.
9
Prevalence of pulmonary tuberculosis among prison inmates: A cross-sectional survey at the Correctional and Detention Facility of Abidjan, Côte d'Ivoire.科特迪瓦阿比让惩教与拘留设施中监狱囚犯肺结核患病率:一项横断面调查
PLoS One. 2017 Jul 31;12(7):e0181995. doi: 10.1371/journal.pone.0181995. eCollection 2017.
10
Assessments of serum copper and zinc concentration, and the Cu/Zn ratio determination in patients with multidrug resistant pulmonary tuberculosis (MDR-TB) in Côte d'Ivoire.对科特迪瓦多药耐药性肺结核(MDR-TB)患者的血清铜和锌浓度进行评估,并测定铜/锌比值。
BMC Infect Dis. 2017 Apr 11;17(1):257. doi: 10.1186/s12879-017-2343-7.

引用本文的文献

1
The Relevance of Genomic Epidemiology for Control of Tuberculosis in West Africa.基因组流行病学对于西非结核病控制的相关性。
Front Public Health. 2021 Jul 23;9:706651. doi: 10.3389/fpubh.2021.706651. eCollection 2021.
2
High rates of multidrug-resistant and rifampicin-resistant tuberculosis among re-treatment cases: where do they come from?复治病例中耐多药和耐利福平结核病的高发生率:其来源何在?
BMC Infect Dis. 2017 Jan 6;17(1):36. doi: 10.1186/s12879-016-2171-1.

本文引用的文献

1
High prevalence of shared international type 53 among Mycobacterium tuberculosis complex strains in retreated patients from Côte d'Ivoire.在来自科特迪瓦的复治患者中,结核分枝杆菌复合群菌株中存在高比例的共同国际 53 型。
PLoS One. 2012;7(9):e45363. doi: 10.1371/journal.pone.0045363. Epub 2012 Sep 18.
2
Availability of anti-tuberculosis drugs in Europe.欧洲抗结核药物的可及性。
Eur Respir J. 2012 Aug;40(2):500-3. doi: 10.1183/09031936.00009212.
3
Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010.
全球抗结核药物耐药性监测:2007-2010 年更新分析。
Bull World Health Organ. 2012 Feb 1;90(2):111-119D. doi: 10.2471/BLT.11.092585. Epub 2011 Nov 7.
4
Multidrug-resistant tuberculosis today.当今的耐多药结核病
Bull World Health Organ. 2012 Feb 1;90(2):78. doi: 10.2471/BLT.11.097360.
5
Totally drug-resistant tuberculosis in India.印度的完全耐药结核病
Clin Infect Dis. 2012 Feb 15;54(4):579-81. doi: 10.1093/cid/cir889. Epub 2011 Dec 21.
6
The global rise of extensively drug-resistant tuberculosis: is the time to bring back sanatoria now overdue?广泛耐药结核病在全球范围内的增多:现在恢复疗养院制度是否为时已晚?
Lancet. 2012 Feb 25;379(9817):773-5. doi: 10.1016/S0140-6736(11)61062-3. Epub 2011 Oct 25.
7
Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk.白俄罗斯令人震惊的耐多药结核病水平:明斯克调查结果。
Eur Respir J. 2012 Jun;39(6):1425-31. doi: 10.1183/09031936.00145411. Epub 2011 Oct 17.
8
Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities.资源匮乏国家的结核病实验室诊断:挑战与机遇。
Clin Microbiol Rev. 2011 Apr;24(2):314-50. doi: 10.1128/CMR.00059-10.
9
[Antituberculous retreatement in case of failure to category I regimen].[初治失败时的抗结核再治疗]
Rev Mal Respir. 2010 Nov;27(9):1055-61. doi: 10.1016/j.rmr.2010.04.016. Epub 2010 Oct 29.
10
Health systems financing and the path to universal coverage.卫生系统筹资与全民覆盖之路。
Bull World Health Organ. 2010 Jun;88(6):402. doi: 10.2471/BLT.10.078741.